BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (BMEZ) is a closed-end management investment company that aims to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust, founded on August 14, 2019, and headquartered in Wilmington, DE, is managed by BlackRock Advisors, LLC. It trades on the New York Stock Exchange under the ticker symbol BMEZ. Under normal market conditions, BMEZ invests at least 80% of its total assets in equity securities of companies primarily engaged in the health sciences group of industries and equity derivatives with exposure to this sector. This investment universe includes businesses in biotechnology, pharmaceuticals, medical devices, healthcare services, and life sciences tools and equipment. The fund may invest in companies of various sizes and stages of development, both in the United States and internationally, offering exposure to the global healthcare and life sciences industries. BMEZ is structured as a term trust, designed to return assets to shareholders and terminate on a specified future date, subject to governing documents and shareholder or board actions. Sources: [1] https://stockanalysis.com/stocks/bmez/ [2] https://robinhood.com/us/en/stocks/BMEZ/ [3] https://www.stocktitan.net/overview/BMEZ/ [4] https://www.marketbeat.com/stocks/NYSE/BMEZ/ [5] https://cbonds.com/etf/197904/ [6] https://www.blackrock.com/us/individual/products/312196/blackrock-health-sciences-trust-ii-class [7] https://www.morningstar.com/cefs/xnys/bmez/strategy [8] https://www.cefconnect.com/fund/BMEZ [9] https://www.gurufocus.com/stock/BMEZ/summary